Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

NCT04118855 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04118855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04118855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Lead sponsor
RenJi Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2020
Completion date
March 31, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoadjuvant therapy of non-metastatic locally advanced renal cell carcinoma